Skip to main content
SpringerLink
Log in

Nomifensine, TRH and insulin-induced hypoglycemia tests in the diagnosis of prolactinomas

  • Original Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Nomifensine, TRH and insulin-induced hypoglycemia tests were carried out in 37 cases of hyperprolactinemia: 25 were due to PRL-secreting pituitary tumors, 6 cases to GH and PRL-secreting pituitary tumors and 6 to pituitary and suprasellar non secreting tumors. Nomifensine failed to suppress the serum PRL in all subjects and PRL responses to TRH and insulin-induced hypoglycemia were impaired in all patients, irrespective of the origin of hyperprolactinemia. The uniform pattern of PRL response to the above tests in patients with hyperprolactinemia of variable etiology suggests that none of them is specific for prolactinomas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Faglia G., Beck-Peccoz P., Travaglini P., Ambrosi B., Rondena M., Paracchi A., Spada A., Weber G., Bara R., Bonzin A. Functional studies in hyperprolactinemic states In: Crosignani P.G., Robyn C. (Eds), Prolactin and human reproduction. Academic Press, London - New York, 1977, p. 225.

    Google Scholar 

  2. Frantz A.G. Prolactin N.Engl. J. Med., 298: 201, 1978.

    Article  PubMed  CAS  Google Scholar 

  3. Cowden E.A., Ratcliffe J.G., Thomson J.A., Macpherson P., Doyle D., Teasdale G.M. Tests of prolactin secretion in diagnosis of prolactinomas. Lancet 1: 1155, 1979.

    Article  PubMed  CAS  Google Scholar 

  4. Assies J., Schellekens A.P.M., Touber J.L. The value of an intravenous TRH test for the diagnosis of tumoural prolactinaemia. Acta Endocrinol. (Kbh) 94: 439, 1980.

    CAS  Google Scholar 

  5. Müller E.E., Genazzani A.R., Murru S. Nomifensine: diagnostic test in hyperprolactinemic states. J. Clin. Endocrinol. Metab. 47: 1352, 1978.

    Article  PubMed  Google Scholar 

  6. Hunt P., Kannengiesser M.H., Raynaud J.P. Nomifensine a new potent inhibitor of dopamine uptake into synaptosomes from rat corpus striatum. J. Pharm. Pharmacol. 26: 370, 1974.

    Article  PubMed  CAS  Google Scholar 

  7. Gerhards H.G., Carenzi A., Costa E. Effects of Nomifensine on motor activity, dopamine turnover rate and cyclic 3′, 5′ — adenosine monophosphate concentrations of rat striatum. Naunyn Schmiedebergs Arch. Pharmacol. 286: 49, 1974.

    Article  PubMed  CAS  Google Scholar 

  8. Genazzani A.R., Camanni F., Massara F., Picciolini E., Cocchi D., Belforte L., Müller E.E. A new pharmacological approach to the diagnosis of hyperprolactinemic states: the nomifensine test. Acta Endocrinol. (Kbh) 93: 139, 1980.

    CAS  Google Scholar 

  9. Müller E.E., Genazzani A.R., Camanni F., Cocchi D., Massara F., Picciolini E., Locatelli V., Molinatti G.M. Neuropharmacological approach to the diagnosis and treatment of secreting pituitary adenomas. In: Faglia G., Giovanelli M.A., Mc Leod R.M. (Eds), Pituitary microadenomas Academic Press. London, New York, 1980, p. 34.

    Google Scholar 

  10. Ferrari C., Crosignani P.G., Caldara R., Picciotti M.C., Malinverni A., Barattini B., Rampini P., Telloli P. Failure of Nomifensine administration to discriminate between tumorous and non tumorous hyperprolactinaemia. J. Clin. Endocrinol. Metab. 50: 23, 1979.

    Article  Google Scholar 

  11. Moriondo P., Travaglini P., Nissim M., Faglia G. Evaluation of two inhibitory tests (nomifensine and L- dopa + carbidopa) for the diagnosis of hyperprolacti nemic states Clin. Endocrinol. (Oxf.) 13: 525, 1980.

    Article  CAS  Google Scholar 

  12. Kamoi K., Tchuchida I.. Stato H., Tanaka R., Ishiguro T., Kaneko K., Iwasaki Y., Shibata A. Comparison of the response in the Nomifensine test with hyperprolactinaemia du to prolactin-secreting pituitary tumors and non prolactin secreting hypothalamic tumors. J. Clin. Endocrinol. Metab. 53: 1285, 1981.

    Article  PubMed  CAS  Google Scholar 

  13. Camanni F., Genazzani A.R., Massara F., De Leo V., Molinatti G.M., Muller E.E. Prolactin responsiveness to Nomifensine in patients with hyperprolactinemia of tumorous or uncertain etiology. J. Clin. Endocrinol. Metab. 51: 650, 1980.

    Article  PubMed  CAS  Google Scholar 

  14. Horvath E., Kovacs K. Ultrastructural classification of pituitary adenomas Canad. J. Neurol. Sci. 3: 9, 1976.

    PubMed  CAS  Google Scholar 

  15. Capella C., Usellini L., Frigerio B., Buffa R., Fontana P., Solcia E. Argyrophil pituitary tumors showing TSH cells or small granule cells. Vjrchows Arch. (Path. Anat.) 381: 295, 1979.

    Article  CAS  Google Scholar 

  16. Fine S.A., Frohman L.A. Loss of central nervous system component of dopaminergic inhibition of prolactin secretion in patients with prolactin secreting pituitary tumours. J. Clin. Invest. 61: 973, 1978.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  17. Van Loon G.R. A defect in catecholamine neurons in patients with prolactin secreting pituitary adenoma. Lancet 2: 868, 1978.

    PubMed  Google Scholar 

  18. Quigley M.E., Judd S.J., Gilliland G.B., Yen S.S.C. Effects of a dopamine antagonist on the release of go nadotropin and prolactin in normal women and women with hyperprolactinemic anovulation. J. Clin. Endocrinol. Metab. 48: 718, 1979.

    Article  PubMed  CAS  Google Scholar 

  19. Scanlon M.F., Pourmand M., Mc Gregor A.M., Rodriguez- Arnao M.D., Hall K., Gomez-Pan A., Hall R. Some current aspects of clinical and experimental neuroendocrinology with particular reference to growth hormone, thyrotropin and prolactin. J. Endocrinol. Invest. 2: 307, 1979.

    Article  PubMed  CAS  Google Scholar 

  20. Beck W., Hancks J.L., Wuttke W. Increased sensivity of dopaminergic inhibition of luteining hormone release in immature and castrated female rats. Endocrinology 102: 837, 1978.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Divisione “B” di Medicina Generale, Istochimica ed Ultrastrutturale dell’Università di Pavia, Varese. Ospedale Regionale di Varese, 21100, Varese, Italy

    F. Iannotta & G. Pinotti

  2. Divisione di Neurochirurgia, Istochimica ed Ultrastrutturale dell’Università di Pavia, Varese. Ospedale Regionale di Varese, 21100, Varese, Italy

    P. Fachinetti

  3. Medicina Nucleare e, Istochimica ed Ultrastrutturale dell’Università di Pavia, Varese. Ospedale Regionale di Varese, 21100, Varese, Italy

    A. Fachinetti

  4. Centro di Diagnostica Istopatologica, Istochimica ed Ultrastrutturale dell’Università di Pavia, Varese. Ospedale Regionale di Varese, 21100, Varese, Italy

    L. Usellini

Authors
  1. F. Iannotta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Fachinetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Fachinetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G. Pinotti
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. L. Usellini
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Iannotta, F., Fachinetti, P., Fachinetti, A. et al. Nomifensine, TRH and insulin-induced hypoglycemia tests in the diagnosis of prolactinomas. J Endocrinol Invest 6, 353–358 (1983). https://doi.org/10.1007/BF03347615

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03347615

Key-words

Search

Navigation